Showing 1 - 20 results of 44 for search 'Andrew M. Scott', query time: 0.07s
Refine Results
-
1
-
2
Standard of care in immunotherapy trials: Challenges and considerations by Gareth Rivalland, Andrew M. Scott, Thomas John
Published 2017-09-01
Article -
3
Eph Receptors in Cancer by Sakshi Arora, Andrew M. Scott, Peter W. Janes
Published 2023-01-01
Article -
4
-
5
Antibody-drug conjugates: beyond current approvals and potential future strategies by Siddharth Menon, Sagun Parakh, Andrew M. Scott, Hui K. Gan
Published 2022-04-01
Article -
6
-
7
Antibody–Drug Conjugates for Cancer Therapy by Umbreen Hafeez, Sagun Parakh, Hui K. Gan, Andrew M. Scott
Published 2020-10-01
Article -
8
Mediators and clinical treatment for cancer cachexia: a systematic review by Zhipeng Cao, Andrew M. Scott, Nick J. Hoogenraad, Laura D. Osellame
Published 2021-07-01
Article -
9
Antibody Targeting of Eph Receptors in Cancer by Peter W. Janes, Mary E. Vail, Hui K. Gan, Andrew M. Scott
Published 2020-05-01
Article -
10
-
11
-
12
-
13
-
14
Clinical and research updates on the VISTA immune checkpoint: immuno-oncology themes and highlights by Randolph J. Noelle, Randolph J. Noelle, J. Louise Lines, Lionel D. Lewis, Robert E. Martell, Robert E. Martell, Thierry Guillaudeux, Sam W. Lee, Kathleen M. Mahoney, Kathleen M. Mahoney, Matthew D. Vesely, Jerome Boyd-Kirkup, Dhanya K. Nambiar, Andrew M. Scott, Andrew M. Scott
Published 2023-09-01
Article -
15
The Plasticity of Oncogene Addiction: Implications for Targeted Therapies Directed to Receptor Tyrosine Kinases by Vinochani Pillay, Layal Allaf, Alexander L. Wilding, Jacqui F. Donoghue, Naomi W. Court, Steve A. Greenall, Andrew M. Scott, Terrance G. Johns
Published 2009-05-01
Article -
16
-
17
-
18
Internalization, Intracellular Trafficking, Biodistribution of Monoclonal Antibody 806: A Novel Anti-Epidermal Growth Factor Receptor Antibody by Rushika M. Perera, Roberto Zoncu, Terrance G. Johns, Marc Pypaert, Fook-Thean Lee, Ira Mellman, Lloyd J. Old, Derek K. Toomre, Andrew M. Scott
Published 2007-12-01
Article -
19
A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells. by Benjamin J Solomon, Jayesh Desai, Mark Rosenthal, Grant A McArthur, Scott T Pattison, Stacey L Pattison, Jennifer MacDiarmid, Himanshu Brahmbhatt, Andrew M Scott
Published 2015-01-01
Article -
20
Non-agonistic bivalent antibodies that promote c-MET degradation and inhibit tumor growth and others specific for tumor related c-MET. by Sameer A Greenall, Ermanno Gherardi, Zhanqi Liu, Jacqueline F Donoghue, Angela A Vitali, Qian Li, Roger Murphy, Luisa Iamele, Andrew M Scott, Terrance G Johns
Published 2012-01-01
Article